Should You Buy Baxter International Inc (BAX) Stock After it Has Gained 0.73% in a Week?

The market has been neutral on Baxter International Inc (BAX) stock recently. BAX gets a Neutral score from InvestorsObserver Stock Sentiment Indicator.

Baxter International Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on BAX!

See Full BAX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With BAX Stock Today?

Baxter International Inc (BAX) stock is trading at $55.40 as of 11:58 AM on Monday, Nov 28, a decline of -$0.60, or -1.07% from the previous closing price of $56.00. The stock has traded between $55.28 and $56.03 so far today. Volume today is light. So far 1,755,247 shares have traded compared to average volume of 4,670,224 shares.

More About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. The company offers contract manufacturing services to pharmaceutical companies. The Hillrom transaction has added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's 2021 revenue came from more digitally connected offerings like its smart beds and Voalte medical communications app. Click Here to get the full Stock Report for Baxter International Inc stock.